HLA-S and neoplasm: It is calculated by incorporating four key tumor immunogenicity determining factors, including effector cells, checkpoints/immunomodulators, antigen processing major histocompatibility complex (MHC) molecules (e.g., HLAs), and immunosuppressive cells.